Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients

References

• MohamedM, MenonM, NebeyouS, MahtemeB, WondimagegnT, DanielS. Blood and tissue enzymatic activities of GDH and LDH, index of glutathione, and oxidative stress among breast cancer patients attending Referral Hospitals of Addis Ababa, Ethiopia: hospital-based comparative cross-sectional study. Oxid Med Cell Longev. 2018;2018:12.
   Web of Science ®Google Scholar
• FerlayJ, SoerjomataramI, DikshitR, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• AndersonBO, ShyyanR, EniuA, et al. Breast Cancer in Limited‐Resource Countries: an Overview of the Breast Health Global Initiative 2005 Guidelines. Breast J. 2006;12(s1):S3–S15. doi:10.1111/j.1075-122X.2006.00199.x16430397
   PubMed Web of Science ®Google Scholar
• TfayliA, TemrazS, Abou MradR, ShamseddineA. Breast cancer in low-and middle-income countries: an emerging and challenging epidemic. J Oncol. 2010;2010. doi:10.1155/2010/490631
   Google Scholar
• BartschJE, StarenED, AppertHE. Matrix metalloproteinase expression in breast cancer. J Surg Res. 2003;110(2):383–392. doi:10.1016/S0022-4804(03)00007-612788669
   PubMed Web of Science ®Google Scholar
• MohamedMM, SloaneBF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer. 2006b;6(10). doi:10.1038/nrc1949
   Web of Science ®Google Scholar
• DumasJE, PlattMO. Systematic optimization of multiplex zymography protocol to detect active cathepsins K, L, S, and V in healthy and diseased tissue: compromise among limits of detection, reduced time, and resources. Mol Biotechnol. 2013;54(3):1038–1047.23532386
   PubMed Web of Science ®Google Scholar
• BarryZT, PlattMO. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation. J Biol Chem. 2012;287(33):27723–27730. doi:10.1074/jbc.M111.33268422730330
   PubMed Web of Science ®Google Scholar
• DasS, BanerjiA, FreiE, ChatterjeeA. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008;82(9):467–476. doi:10.1016/j.lfs.2007.12.01318243246
   PubMed Web of Science ®Google Scholar
• DuffyM, McCarthyK. Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review).. Int J Oncol. 1998;12(6):1343–1348. doi:10.3892/ijo.12.6.13439592197
   PubMed Web of Science ®Google Scholar
• HirvonenR, Talvensaari-MattilaA, PaakkoP, Turpeenniemi-HujanenT. Matrix Metalloproteinase-2 (MMP-2) in T1-2 N0 breast carcinoma. Breast Cancer Res Treat. 2003;77(1):7.
   Web of Science ®Google Scholar
• La RoccaG, Pucci-MinafraI, MarrazzoA, TaorminaP, MinafraS. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer. 2004;90(7):1414–1421. doi:10.1038/sj.bjc.660172515054465
   PubMed Web of Science ®Google Scholar
• KalliS, SemineA, CohenS, NaberSP, MakimSS, BahlM. American joint committee on cancer’s staging system for breast cancer: what the radiologist needs to know. Radiographics. 2018;38(7):1921–1933. doi:10.1148/rg.201818005630265613
   PubMed Web of Science ®Google Scholar
• AminMB, GreeneFL, EdgeSB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• SmithKM, XuY. Tissue sample preparation in bioanalytical assays. Bioanalysis. 2012;4(6):741–749. doi:10.4155/bio.12.1922452264
   PubMed Web of Science ®Google Scholar
• ChenB, PlattMO. Multiplex zymography captures stage-specific activity profiles of cathepsins K, L, and S in human breast, lung, and cervical cancer. J Transl Med. 2011;9(1):109. doi:10.1186/1479-5876-9-10921756348
   PubMed Web of Science ®Google Scholar
• Akin-OdanyeE, AsuzuCC, PopoolaOA. Measured effect of some socio-demographic factors on depression among breast cancer patients receiving chemotherapy in Lagos State University Teaching Hospital (LASUTH). Afr Health Sci. 2011;11:3.
   Web of Science ®Google Scholar
• DumasJE, PlattMO. Systematic optimization of multiplex zymography protocol to detect active cathepsins K, L, S, and V in healthy and diseased tissue: compromise among limits of detection, reduced time, and resources. Mol Biotechnol. 2013;54(3):1038–1047.23532386
   PubMed Web of Science ®Google Scholar
• MillerBA, HankeyBF, ThomasTL. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol. 2002;155(6):534–545. doi:10.1093/aje/155.6.53411882527
   PubMed Web of Science ®Google Scholar
• JingaD, BlidaruA, CondreaI, et al. MMP‐9 and MMP‐2 gelatinases and TIMP‐1 and TIMP‐2 inhibitors in breast cancer: correlations with prognostic factors. J Cell Mol Med. 2006;10(2):499–510. doi:10.1111/j.1582-4934.2006.tb00415.x16796815
   PubMed Web of Science ®Google Scholar
• QuarantaM, DanieleA, CovielloM, et al. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res. 2007;27(5B):3593–3600.17972522
   PubMed Web of Science ®Google Scholar
• ScorilasA, KaramerisA, ArnogiannakiN, et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients. Br J Cancer. 2001;84(11):1488.11384099
   PubMed Web of Science ®Google Scholar
• ReichR, SupuranCT, BreuerE. Tumor microenvironment as target in cancer therapy. Annual Rep Med Chem. 2014;49:269–284.
   Web of Science ®Google Scholar
• ScorilasA, KaramerisA, ArnogiannakiN, et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer. 2001;84(11):1488–1496. doi:10.1054/bjoc.2001.181011384099
   PubMed Web of Science ®Google Scholar
• PellikainenJM, RopponenKM, KatajaVV, KellokoskiJK, EskelinenMJ, KosmaV-M. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res. 2004;10(22):7621–7628. doi:10.1158/1078-0432.CCR-04-106115569994
   PubMed Web of Science ®Google Scholar
• TêtuB, BrissonJ, WangCS, et al. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res. 2006;8(3):R28. doi:10.1186/bcr150316776850
   PubMed Web of Science ®Google Scholar
• SolomonTZymographic detection and clinical correlations of cysteine cathepsins and Matrix Metalloproteases in Human Breast Cancer Tissue: AAU; 2016. Available from:http:/etd.aau.edu.et/handle/1234567892995. Accessed 191 2020
   Google Scholar